Literature DB >> 12428028

Epilepsy after brain insult: targeting epileptogenesis.

Susan T Herman1.   

Abstract

Seizures and epilepsy are common sequelae of acute brain insults such as stroke, traumatic brain injury, and central nervous system infections. Early, or acute symptomatic, seizures occur at the time of the brain insult and may be a marker of severity of injury. A cascade of morphologic and biologic changes in the injured area over months to years leads to hyperexcitability and epileptogenesis. After a variable latency period, late unprovoked seizures and epilepsy occur. The latent period may offer a therapeutic window for the prevention of epileptogenesis and the development of unprovoked seizures and epilepsy. Administration of anticonvulsant drugs following acute brain insults has thus far failed to prevent late epilepsy. Proper choice of disease models and target populations will aid in the development of putative antiepileptogenic agents. The incidence, timing, and pathophysiology of common epileptogenic brain injuries, including head trauma, cerebrovascular disease, brain tumors, neurosurgical procedures, neurodegenerative conditions, status epilepticus, and febrile seizures, are reviewed.

Entities:  

Mesh:

Year:  2002        PMID: 12428028     DOI: 10.1212/wnl.59.9_suppl_5.s21

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  103 in total

Review 1.  Brain extracellular space, hyaluronan, and the prevention of epileptic seizures.

Authors:  Katherine L Perkins; Amaia M Arranz; Yu Yamaguchi; Sabina Hrabetova
Journal:  Rev Neurosci       Date:  2017-11-27       Impact factor: 4.353

2.  Statistical parametric mapping reveals regional alterations in cannabinoid CB1 receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain.

Authors:  Katherine W Sayers; Peter T Nguyen; Robert E Blair; Laura J Sim-Selley; Robert J DeLorenzo
Journal:  Epilepsia       Date:  2012-04-17       Impact factor: 5.864

3.  An organotypic hippocampal slice culture model of excitotoxic injury induced spontaneous recurrent epileptiform discharges.

Authors:  Julie M Ziobro; Laxmikant S Deshpande; Robert J Delorenzo
Journal:  Brain Res       Date:  2010-11-25       Impact factor: 3.252

Review 4.  Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research.

Authors:  Wolfgang Löscher; Claudia Brandt
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

5.  Mesial temporal sclerosis as a complication of hematologic cancer.

Authors:  Rafael Sivera; Luis Bataller; Jesús Martínez; Vicente Villanueva
Journal:  J Neurol       Date:  2009-05-12       Impact factor: 4.849

Review 6.  Selective vulnerability of hippocampal interneurons to graded traumatic brain injury.

Authors:  Jan C Frankowski; Young J Kim; Robert F Hunt
Journal:  Neurobiol Dis       Date:  2018-07-19       Impact factor: 5.996

7.  Harmonization of pipeline for preclinical multicenter MRI biomarker discovery in a rat model of post-traumatic epileptogenesis.

Authors:  Riikka Immonen; Gregory Smith; Rhys D Brady; David Wright; Leigh Johnston; Neil G Harris; Eppu Manninen; Raimo Salo; Craig Branch; Dominique Duncan; Ryan Cabeen; Xavier Ekolle Ndode-Ekane; Cesar Santana Gomez; Pablo M Casillas-Espinosa; Idrish Ali; Sandy R Shultz; Pedro Andrade; Noora Puhakka; Richard J Staba; Terence J O'Brien; Arthur W Toga; Asla Pitkänen; Olli Gröhn
Journal:  Epilepsy Res       Date:  2019-01-07       Impact factor: 3.045

8.  Aberrant excitatory rewiring of layer V pyramidal neurons early after neocortical trauma.

Authors:  D Koji Takahashi; Feng Gu; Isabel Parada; Shri Vyas; David A Prince
Journal:  Neurobiol Dis       Date:  2016-03-05       Impact factor: 5.996

Review 9.  Epilepsy related to traumatic brain injury.

Authors:  Asla Pitkänen; Riikka Immonen
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

10.  Decoding hippocampal signaling deficits after traumatic brain injury.

Authors:  Coleen M Atkins
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.